LIFE Ethos Technologies Inc. Class A Common Stock

XNAS 35.17 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

LIFE $35.17 —
Key stats
$35.17
52-Week Range
$9.45 – $49.98
YTD
+108.72%
IV Rank (30D)
9.71
Straddle Price
$6.40
P/C Vol Ratio
0.04
Market Cap
$2.2B
Open
$34.12
Day Range
$33.76 – $36.59
Volume
776,553
Prev Close
$33.51
Fair Value
MODEL: SHORT

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.90%
Beta vs SPY0.60
Cost of Equity (CAPM)7.91% (VRP-adj)
WACC8.41%
Volatility Risk Premium+19.7pp (IV − HV30)
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+30.0%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.10 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.1B
Return on Equity (TTM)-28.1%
Book / Price21.6%
Gross Margin (TTM)98.2%
FCF Margin (TTM)-13.2%
Debt / Equity0.00
Quality Score3/6 — normal (10y DCF)
SMA 50$38.08 (Market Anchor value)
SMA 20 / Bollinger Mid$40.22
Bollinger Width / SMA2032.5% (drives anchor stability)
Net Debt$-0.1B
Market Cap$2B
Peers used for multiples: AJG, AON, BRO, EQH, ERIE, MMC, MRSH, WTW
60-Day Conviction
93%
20-Day Fair Value
≈ by Dec 8, 2026
$35.25
α -0.2% rank 39%
conviction
13%
40-Day Fair Value
≈ by Jan 6, 2027
$34.81
α -1.4% rank 39%
conviction
50%
60-Day Fair Value
≈ by Feb 4, 2027
$33.28
α -5.7% rank 39%
conviction
93%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 22.6× · 6 peers
Peer EV/EBITDA n/a 0% median 17.5× · 7 peers
Peer P/B $36.45 30% median 5.0× · 6 peers
Peer P/S $28.05 30% median 3.5× · 7 peers
Market Anchor (SMA50) $38.08 0% stability 0% (BB-width)
Options Expected (B-L 30d) $33.02 39% 10 strikes · skew -0.34
As of 2026-11-09 · updated
About
Industry (SIC)
INSURANCE AGENTS, BROKERS & SERVICE (6411) · industry map
Exchange
XNAS
Market Cap
$2.2B
Employees
614
List Date
2026-01-29
CIK
0001788451
Last Earnings
Nov 2 after close · −4.1% vs ±22.2% expected
Headquarters
Austin, TX
Homepage
https://www.ethos.com

Ethos Technologies Inc operates a technology-driven, direct-to-consumer platform for the distribution of life insurance products. Through its digital underwriting, data analytics, and proprietary technology, it enables consumers to explore, compare, and purchase life insurance policies online. The platform serves consumers, agents, and insurance carriers, and supports the application and policy issuance process through an online interface. The company works with insurance carriers to offer life insurance products in the United States through digital channels and independent agents. It generate…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
Month'21'22'23'24'26Avg
Jan-7.56%-24.54%-2.54%6.69%-10.68%-7.73%
Feb15.08%-14.19%-7.05%20.00%-11.15%0.54%
Mar-4.71%7.21%1.94%2.09%-11.28%-0.95%
Apr-11.38%-25.58%-7.14%-17.80%57.59%-0.86%
May10.46%-32.94%8.10%8.81%1.34%-0.85%
Jun5.63%1.43%-4.85%2.70%-3.92%0.20%
Jul-6.80%23.16%-12.11%--4.29%2.14%
Aug18.09%-4.74%-13.71%--59.13%14.69%
Sep66.30%-9.37%-7.06%---4.09%11.45%
Oct0.35%-13.64%-17.22%--33.22%0.68%
Nov-4.58%-13.25%5.69%---16.76%*-7.23%
Dec-7.66%-3.95%11.02%-----0.20%
Total69.63%-73.11%-39.61%20.06%90.69%13.53%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $40.12
SMA 50: $38.02
SMA 200: $23.14
Current: $35.31
EMA 12: $38.26
EMA 26: $38.60
MACD: -0.3451 | Signal: -1.1728
BULLISH
ADX (14): 24.44
WEAK TREND
+DI: 26.56
−DI: 21.47

Momentum Oscillators

RSI (14): 41.19
NEUTRAL
Stoch %K: 7.62
Stoch %D: 6.94
Williams %R: -83.83

Volume & Volatility

BB Upper: $46.90
BB Lower: $33.34
NEUTRAL
OBV: 34,723,769
Vol SMA 20: 1,692,154
Vol ROC: 3.43%
ATR: $3.11
True Range: $3.08
HV 20: 79.0%
HV 30: 70.0%
HV 60: 65.8%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2023-03-21T00:00:00 – 2026-11-06T00:00:00
AI Analysis
Written before LIFE’s Nov 2 earnings report, so it doesn’t reflect the results.

LIFE Stock Analysis Report

⚠️ CRITICAL DATA QUALITY ISSUE

This analysis contains a fundamental data integrity problem that significantly undermines confidence in all conclusions:

The news headlines reference aTyr Pharma (ticker symbol change from LIFE to ATYR on June 3, 2024), yet the current price is dated as $36.96 with next earnings listed as 2026-11-02 (future date). This suggests either:

  1. The data is conflating two different entities
  2. LIFE may have been reassigned to a different company post-ticker change
  3. Data timestamps are inconsistent or the dataset is corrupted

Recommendation: Verify current LIFE ticker ownership and confirm all data sources are current and aligned before making any investment decisions.


Executive Summary

Overall Assessment: NEUTRAL (Confidence: 3/10 - LOW)

This analysis is severely compromised by data quality issues. However, based on the technical data provided in isolation: The stock shows mixed technical signals with bullish momentum indicators (MACD bullish crossover, RSI neutral at 56) but conflicting news context, extremely low beta (0.07), and an unusual options market profile suggesting significant expected volatility ($11.47 move over 42 DTE).

Key Drivers:

  • Strong uptrend structure (price 2.4% above SMA-20, well above SMA-200)
  • Bullish MACD histogram with RSI in neutral zone
  • Extremely low systematic risk (beta 0.07) suggests idiosyncratic, not market-driven movement

Primary Risks:

  • Data ambiguity regarding company identity
  • Extraordinarily high implied volatility (111.5% IV) vs historical volatility (54-70.5% HV20-60)
  • Volume declining (-20.37% rate of change)
  • Extreme skew in options market (247 calls vs 3 puts)

Investment Thesis: The technical setup is constructive with price above key moving averages and positive MACD momentum, but the massive IV premium (85.1% above realized volatility), extremely lopsided call/put ratio, and data quality concerns suggest this is a speculative positioning rather than a fundamentally supported move.


Technical Analysis

Trend Direction

| Timeframe | Direction | Confidence | Signal | |-----------|-----------|-----------|--------| | Short-term (1-4 weeks) | BULLISH | Medium | Price $36.96 > SMA20 $35.72; MACD bullish with positive histogram | | Medium-term (1-3 months) | BULLISH | Medium | Price > SMA50 $35.03; sustained above these levels | | Long-term (3-12 months) | STRONG BULLISH | High | Price $36.96 >> SMA200 $19.12 (+93.4%); multi-month uptrend evident |

Support & Resistance Levels

| Level | Type | Technical Basis | Implication | |-------|------|-----------------|-------------| | $31.86 | SUPPORT | Lower Bollinger Band | Primary downside protection; 13.8% below current | | $35.03 | SUPPORT | SMA-50 | Intermediate support; psychological level | | $35.72 | SUPPORT | SMA-20 | Near-term support; relatively tight | | $39.59 | RESISTANCE | Upper Bollinger Band | Strong technical ceiling; 7.1% upside | | $42.00+ | RESISTANCE | ATR-based projection | Extended move would require momentum acceleration |

Key Observation: Wide distance between current price and SMA-200 ($19.12) suggests either significant revaluation event or data anomaly (possible ticker reassignment with gap adjustment).

Momentum Signals

RSI (14) = 56.01 - NEUTRAL

  • Reading in middle of 30-70 range indicates balanced momentum
  • Not overbought (>70) nor oversold (<30)
  • Suggests room for directional movement either direction
  • Slightly bullish positioning above 50 midpoint

MACD = 0.11 / Signal = -0.01 / Histogram = +0.12 - BULLISH EARLY SIGNAL

  • MACD line (0.11) recently crossed above signal line (-0.01)
  • Positive histogram (+0.12) confirms bullish crossover
  • Early stage bullish momentum; not yet extended
  • Suggests potential acceleration phase

Stochastic %K = 70.09 / %D = 59.16 - EARLY OVERBOUGHT

  • %K at 70.09 indicates overbought conditions (>70 territory)
  • %D at 59.16 hasn't caught up, suggesting momentum still building
  • Classic setup for potential pullback to consolidation
  • Watch for %K rolling over below %D as early warning signal

Williams %R = -16.91 - NEUTRAL TO BULLISH

  • Reading between -20 and 0 indicates strong momentum
  • Not yet at -100 (fully oversold) or 0 (overbought)
  • Suggests continued upside potential

Conflicting Signal: Stochastic overbought (%K 70.09) vs RSI neutral (56.01) suggests momentum is gaining but not yet overextended—classic mid-move position.

Bollinger Bands Analysis

Position: Price $36.96 between middle ($35.72) and upper band ($39.59)

  • 36.4% of the way through upper half
  • Signal: Neutral (per indicator data)
  • Bands width = 21.62 (moderate expansion, not extreme squeeze)
  • Not at extremes; suggests consolidation phase rather than breakout

Interpretation: Bands are giving neither strong buy (price at lower band) nor strong sell (at upper band) signals. This neutrality combined with positive MACD suggests continuation likely rather than mean-reversion.

Volume Analysis

Volume SMA 20: 1,777,096 shares Volume Rate of Change: -20.37% (declining)

Key Concern: Despite bullish technical setup, volume is declining. This is a red flag for momentum quality:

  • Rising prices on falling volume = potential false signal
  • Suggests fewer participants confirming the uptrend
  • May indicate exhaustion ahead

On-Balance Volume (OBV): 42,258,552.70

  • Cumulative indicator suggests buyers have been accumulating
  • Need prior OBV reading for direction confirmation (data not provided)

Institutional Signal: Volume decline contradicts the bullish technicals—professionals may be distributing into strength rather than accumulating.


News & Sentiment Analysis

News Headlines Summary & Data Integrity Issue

Critical Problem: The news headlines span 2024-2026 and reference aTyr Pharma changing its ticker from LIFE to ATYR on June 3, 2024. This creates fundamental ambiguity:

Headlines Chronology:

  1. 2024-06-03 (aTyr): Ticker symbol change from LIFE to ATYR announced
  2. 2024-05-24 (aTyr): Inducement grants for Nasdaq Rule 5635(c)(4)
  3. 2024-05-19 (General): Wall Street Breakfast commentary
  4. 2024-05-15 (aTyr): Efzofitimod mechanism of action poster for ATS conference
  5. 2024-05-14 (aTyr): Second positive DSMB review for EFZO-FIT Phase 3 study
  6. 2026-09-04 (Ethos): Unrelated—about Ethos Life Insurance company

Sentiment Assessment

| Category | Assessment | Details | |----------|-----------|---------| | Biotech/Drug Pipeline | POSITIVE (historical) | DSMB reviews, conference presentations for pulmonary sarcoidosis treatment positive | | Capital Structure | NEUTRAL | Inducement grants routine for Nasdaq listings | | Corporate Action | NEUTRAL | Ticker change administrative, not fundamental | | Recent (2026) | IRRELEVANT | Ethos headline about life insurance unrelated to this ticker | | Aggregate Sentiment | MIXED-TO-NEUTRAL | Old positive pipeline news conflicts with current data ambiguity |

Catalyst Identification

Immediate/Historical (Already Occurred):

  • ✓ DSMB positive review (May 2024) - positive
  • ✓ Efzofitimod Phase 3 interim data presentations (May 2024)
Generated
Showing 1–10 of 11
Page 1 of 2
Earnings History
1 of 1 under expected move
Avg Expected Move
22.17%
Avg Actual Move
4.08%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2026-11-02 After-Close 22.17% 4.08% 0.18x Within

Earnings calendar: this week’s reports with expected vs actual moves →

LIFE Options Activity & IV Rank

LIFE IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 69.4%
7-DTE IV: 65.2%
Expected Move: $6.40
7-DTE Move: $3.20
Days to Exp: 39 (2026-12-18)

Options Flow · All expiries

Call Volume: 11,034
Put Volume: 412
P/C Volume: 0.037
BULLISH
Call OI: 32,277
Put OI: 959
P/C OI: 0.03
Total OI: 33,236

ATM Options Pricing

ATM Call: $3.50
ATM Put: $2.90
Call %: 10.0%
Put %: 8.2%

Chain Summary

Chain Volume: 11,446
Chain OI: 33,236
Last Updated: 11/9/2026
Spread Scanner

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Scanning bull put, bear call, iron condor and calendar spreads…

Dealer Positioning
HIGH γ vs HISTORY

Estimated net dealer gamma is at the 87th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
87%
vs own history
GEX tilt
+0.97
OI-weighted, today
Vanna tilt
+0.94
δ-sensitivity to IV
Charm tilt
-0.97
δ-decay vs time
Vanna tilt +0.94: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.97: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 9 ATM contracts, 16k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
No data
30 DTE / 10d —
— pts EXTREME
No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Loading the implied volatility surface…

Volatility Smile

Loading the implied volatility smile…

IV Rank (7 DTE)
IV Rank (30 DTE)9.7LowNov 9
Straddle Price (30 DTE)$6.40Nov 9
Beta Analysis

Risk Metrics

Beta: 0.6001
Alpha: 1134.47%
Correlation: 0.0096
R-Squared: 0.0%
Stock Volatility: 893.9%
Market Volatility: 14.4%

Analysis Details

Benchmark: SPY
Data Points: 197
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own LIFE
3 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Renaissance Technologies Hedge fund
Jim Simons
$6.2M
0.01%
#1331 of 3138+328.1%13F
Millennium Management Hedge fund
Izzy Englander
$360K
0.00%
#3293 of 3716new13F
Rockefeller Capital Management Family office
Rockefeller family
$2K
0.00%
#4379 of 4729new13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

LIFE Institutional Ownership (13F)

Filings for 2026-06-30 · 24 already for 2026-09-30
Diluted shares outstanding: 57,746,250 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

79 filers16,181,673 shares$336.09M value28.02% of float
# Filer Shares Value % of Total % of Float Period
1 SOFTBANK GROUP CORP. 3,128,902 $56.76M 16.89% 5.42% 2026-06-30
2 Divisadero Street Capital Management, LP 1,635,921 $29.68M 8.83% 2.83% 2026-06-30
3 T. Rowe Price Investment Management, Inc. 1,582,556 $28.71M 8.54% 2.74% 2026-06-30
4 Jefferies Financial Group Inc. 779,999 $26.18M 7.79% 1.35% 2026-09-30
5 Capital World Investors 1,315,789 $23.87M 7.10% 2.28% 2026-06-30
6 Alphabet Inc. 571,907 $19.20M 5.71% 0.99% 2026-09-30
7 GLYNN CAPITAL MANAGEMENT LLC 476,575 $16.00M 4.76% 0.83% 2026-09-30
8 GLADE BROOK CAPITAL PARTNERS LLC 857,862 $15.56M 4.63% 1.49% 2026-06-30
9 Geode Capital Management, LLC Custodian 286,509 $9.62M 2.86% 0.50% 2026-09-30
10 Vanguard Capital Management LLC 487,570 $8.84M 2.63% 0.84% 2026-06-30
11 UBS Group AG Custodian 417,412 $7.57M 2.25% 0.72% 2026-06-30
12 CANNELL CAPITAL LLC 408,496 $7.41M 2.20% 0.71% 2026-06-30
13 HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 350,000 $6.35M 1.89% 0.61% 2026-06-30
14 Russell Investments Group, Ltd. Custodian 185,474 $6.23M 1.85% 0.32% 2026-09-30
15 RENAISSANCE TECHNOLOGIES LLC 342,500 $6.21M 1.85% 0.59% 2026-06-30
16 The Manufacturers Life Insurance Company 341,279 $6.19M 1.84% 0.59% 2026-06-30
17 Allspring Global Investments Holdings, LLC 145,758 $4.89M 1.46% 0.25% 2026-09-30
18 BARD ASSOCIATES INC 248,220 $4.50M 1.34% 0.43% 2026-06-30
19 Calamos Advisors LLC 126,464 $4.25M 1.26% 0.22% 2026-09-30
20 FEDERATED HERMES, INC. 216,000 $3.92M 1.17% 0.37% 2026-06-30
21 Goldman Sachs Group Inc Custodian 192,459 $3.49M 1.04% 0.33% 2026-06-30
22 Bank of America Corp Custodian 180,482 $3.27M 0.97% 0.31% 2026-06-30
23 BlackRock, Inc. Custodian 172,399 $3.13M 0.93% 0.30% 2026-06-30
24 Two Sigma Investments, LP Custodian 167,778 $3.04M 0.91% 0.29% 2026-06-30
25 Lionhunter Capital Management, LLC 128,000 $2.32M 0.69% 0.22% 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

LIFE Insider Trading (Form 4)

Latest: 2026-10-16
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-10-16 Peter George Colis CEO and Secretary Mixed
Sell −120,000 · Conv +40,000
−80,000 $38.39 -$4.61M EDGAR
2026-10-16 Lingke Wang President Mixed
Sell −118,333 · Conv +118,333
— $38.36 -$4.54M EDGAR
2026-09-18 Peter George Colis CEO and Secretary Mixed
Sell −70,000 · Conv +70,000
— $38.51 -$2.70M EDGAR
2026-09-18 Lingke Wang President Mixed
Sell −118,333 · Conv +118,333
— $38.96 -$4.61M EDGAR
2026-09-10 Roelof Botha Director Other (J) +72,450 — EDGAR
2026-09-10 Sequoia Capital U.S. Growth Fund VIII, L.P. 10%+ Owner Mixed
Other −2,371,501 · Conv +2,371,501
— — EDGAR
2026-08-25 Roelof Botha Director Other (J) +55,167 — EDGAR
2026-08-25 SEQUOIA CAPITAL U.S. VENTURE FUND XV, L.P. 10%+ Owner Mixed
Other −1,778,626 · Conv +1,778,626
— — EDGAR
2026-08-21 Brandt Walter Kucharski Chief Accounting Officer Sell (S) −8,735 $32.47 -$283.7K EDGAR
2026-08-21 Lingke Wang President Mixed
Conv +83,197 · Sell −118,333
−35,136 $33.29 -$3.94M EDGAR
2026-08-21 Peter George Colis CEO and Secretary Mixed
Conv +55,848 · Sell −84,448
−28,600 $33.11 -$2.80M EDGAR
2026-08-21 Nalrena, LLC 10%+ Owner Mixed
Sell −142,616 · Conv +142,616
— $33.05 -$4.71M EDGAR
2026-08-21 SEQUOIA CAPITAL U.S. VENTURE PARTNERS FUND XV (Q), L.P. 10%+ Owner Mixed
Conv +142,616 · Sell −142,616
— $33.05 -$4.71M EDGAR
2026-08-19 Roelof Botha Director Other (J) +51,735 — EDGAR
2026-08-19 SEQUOIA CAPITAL U.S. VENTURE PARTNERS FUND XV (Q), L.P. 10%+ Owner Mixed
Conv +1,778,626 · Other −1,778,626
— — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

LIFE Insider Holdings

21 insiders · @ $35.31
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Accel Growth Fund IV Associates L.L.C. 10%+ Owner 6,780,975 $239.44M $0 1 2026-02-02
2 SOFTBANK GROUP CORP. 10%+ Owner 3,128,902 $110.48M $0 1 2026-02-03
3 GV 2021 GP, L.L.C. 10%+ Owner 2,758,494 $97.40M -$5.11M 2 2026-07-27
4 Accel Growth Fund IV L.P. 10%+ Owner 1,776,327 $62.72M $0 1 2026-08-06
5 GV 2017 GP, L.L.C. 10%+ Owner 1,755,632 $61.99M -$35.06M 1 2026-01-30
6 Peter George Colis CEO and Secretary 1,597,444 $56.41M -$12.43M 7 2026-10-16
7 Lingke Wang President 1,537,543 $54.29M -$14.89M 7 2026-10-16
8 Vipul Sharma Chief Technology Officer 729,217 $25.75M -$3.57M 1 2026-01-30
9 Christopher M. Capozzi Chief Financial Officer 639,044 $22.56M -$2.68M 2 2026-08-18
10 GV 2019 GP, L.P. 10%+ Owner 571,907 $20.19M -$1.83M 1 2026-07-17
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

LIFE Board & Officers

As of SEC filings through Oct 16, 2026

Directors 9

Officers 6

10% owners 26

Changes in the last 10 years (57)
Aug 11, 2026Roelof Botha no longer listed as a 10% owner in SEC filings
Jul 29, 2026Gv 2021, L.p. reported in an SEC filing no longer being a 10% owner
Jul 29, 2026Gv 2021 Gp, L.p. reported in an SEC filing no longer being a 10% owner
Jul 29, 2026Gv 2021 Gp, L.l.c. reported in an SEC filing no longer being a 10% owner
Jul 29, 2026Gv 2019, L.p. reported in an SEC filing no longer being a 10% owner
Jul 29, 2026Gv 2019 Gp, L.p. reported in an SEC filing no longer being a 10% owner
Jul 29, 2026Gv 2019 Gp, L.l.c. reported in an SEC filing no longer being a 10% owner
Jul 29, 2026Alphabet Inc. reported in an SEC filing no longer being a 10% owner
Jan 28, 2026William J Wheeler became a director
Jan 28, 2026Vipul Sharma became Chief Technology Officer
Jan 28, 2026Spelunker Channel Holdings, LLC became a 10% owner
Jan 28, 2026Softbank Vision Fund Ii-2 L.p. became a 10% owner
Jan 28, 2026Softbank Group Corp. became a 10% owner
Jan 28, 2026Sequoia Capital U.s. Venture Xv Principals Fund, L.p. became a 10% owner
Jan 28, 2026Sequoia Capital U.s. Venture Partners Fund Xv, L.p. became a 10% owner
Jan 28, 2026Sequoia Capital U.s. Venture Partners Fund Xv (q), L.p. became a 10% owner
Jan 28, 2026Sequoia Capital U.s. Venture Fund Xv, L.p. became a 10% owner
Jan 28, 2026Sequoia Capital U.s. Scout Seed Fund 2013, L.p. became a 10% owner
Jan 28, 2026Sequoia Capital U.S. Scout IV, L.L.C became a 10% owner
Jan 28, 2026Sequoia Capital U.S. Growth Fund VIII, L.P. became a 10% owner
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

LIFE Proposed Insider Sales (Form 144)

Latest: 2026-10-16
Last 30d: 4 filings · $9.1M notice value  ·  Last 90d: 22 filings · $33.8M notice value · 5 unique filers · 64% under 10b5-1 plans

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Top 90-day filers: Wang Lingke (4, $13.9M) · Colis Peter George (10, $11.1M) · SPELUNKER CHANNEL HOLDINGS LLC (4, $4.7M) · Kucharski Brandt Walter (3, $3.2M) · Capozzi Christopher M. (1, $894K)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-10-16 Colis Peter George Officer, Director 40,000 $1.51M 2026-10-16 Charles Schwab & Co., Inc. 10b5-1 EDGAR
2026-10-15 Wang Lingke Officer, Director 118,333 $4.54M 2026-10-15 Charles Schwab & Co., Inc. 10b5-1 EDGAR
2026-10-15 Colis Peter George Officer, Director 40,000 $1.53M 2026-10-15 Charles Schwab & Co., Inc. 10b5-1 EDGAR
2026-10-14 Colis Peter George Officer, Director 40,000 $1.56M 2026-10-14 Charles Schwab & Co., Inc. 10b5-1 EDGAR
2026-09-18 Colis Peter George Officer, Director 23,333 $859.9K 2026-09-18 Charles Schwab & Co., Inc. 10b5-1 EDGAR
2026-09-17 Wang Lingke Officer, Director 118,333 $4.61M 2026-09-17 Charles Schwab & Co., Inc. 10b5-1 EDGAR
2026-09-17 Colis Peter George Officer, Director 23,333 $906.4K 2026-09-17 Charles Schwab & Co., Inc. 10b5-1 EDGAR
2026-09-16 Colis Peter George Officer, Director 23,334 $929.2K 2026-09-16 Charles Schwab & Co., Inc. 10b5-1 EDGAR
2026-08-21 Colis Peter George Officer, Director 28,600 $954.5K 2026-08-21 Charles Schwab & Co., Inc. 10b5-1 EDGAR
2026-08-20 NALRENA LLC Director 47,898 $1.59M 2026-08-20 Morgan Stanley Smith Barney LLC … — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-11-04
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Event Link
2026-11-02 Earnings results EDGAR
2026-10-09 Other events EDGAR
2026-09-16 Regulation FD disclosure EDGAR
2026-08-03 Earnings results · Other events EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-11-04 0001193125-26-447279 EDGAR
2026-08-05 0001193125-26-335209 EDGAR
ETF Holders
5 ETFs hold LIFE
5 shown · $34.73M total exposure · 0.00% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $23.9M — 2026-09-30
2 VXF Vanguard Extended Market ETF Vanguard 0.01% $9.3M — 2026-09-30
3 ITOT iShares Core S&P Total U.S. Stock Market ETF iShares (BlackRock) 0.00% $1.2M $93.2B 2026-11-06
4 ONEQ Fidelity Nasdaq Composite Index ETF Fidelity 0.00% $314,979 $10.0B 2026-11-05
5 GTO Invesco Total Return Bond ETF Invesco 0.00% $52,183 — 2026-11-05
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-2.96
TTM Revenue
$471.51M
TTM Net Income
$-134.03M
TTM Op. Cash Flow
—
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q2 '262026-06-30$189.56M$19.53M$0.30$35.66M
Q1 '262026-03-31$193.10M$-172.03M$-3.57$31.21M
Q4 '252025-12-31$0.00$-13.96M$-0.14$-12.20M
Q3 '252025-09-30$190.00K$-25.74M$-0.26$-20.48M
Q2 '252025-06-30—$-19.53M$-0.22$-13.89M
Q1 '252025-03-31—$-14.88M$-0.17$-15.42M
Q4 '242024-12-31$0.00$-14.97M$-0.17$-13.13M
Q3 '242024-09-30—$-17.26M$-0.23$-13.16M
Q2 '242024-06-30—$-16.31M$-0.23$-20.45M
Q1 '242024-03-31$235.00K$-15.49M$-0.23$-22.38M
Q4 '232023-12-31$0.00$-14.76M$-0.25$-11.06M
Q3 '232023-09-30$353.00K$-11.34M$-0.20$-9.56M
Q2 2026 • period ending 2026-06-30 • filed 2026-08-05
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
4.30
P/S
4.34
EV/EBITDA
—
EV/Sales
4.11
ROE
-28.1%
ROA
-19.3%
Div Yield
0.00%
FCF Yield
—
Debt/Equity
0.00
Current Ratio
—
Market Cap
$2.05B
as of 2026-11-09

LIFE vs Peers

Related companies, largest first
Company Market cap P/E Revenue growth YTD IV rank
MRSH Marsh $97.4B 24.7 — +12.4% 29
MMC Marsh & McLennan Companies, Inc. $89.5B 21.7 +10.3% +0.1% —
AJG Arthur J. Gallagher & Co. $72.2B 43.2 +25.6% +10.3% 39
AON Aon plc Class A $71.0B 18.5 +3.8% −2.0% 31
WTW Willis Towers Watson Public Limited Comp $30.3B 20.1 +4.8% +0.7% 27
BRO Brown & Brown, Inc. $23.9B 21.4 +27.5% −8.2% 39
ERIE Erie Indemnity Co $14.3B 24.8 +5.0% −2.4% 26
EQH Equitable Holdings, Inc. $14.0B — −6.1% +16.6% 39
LIFE Ethos Technologies Inc. Class A Common S $2.2B — — +109.6% 10
Peer median $50.7B 21.7 +5.0% +0.4% 31

P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.

Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
4.11M
SI % of Float
18.37%
Days to Cover
2.87
Short Vol Ratio
7.7%
Free Float
22.40M
Float %
71.0%
Short interest 2026-10-15 • Short volume 2026-11-06 • Float 2026-08-18